Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluate the Effects of resVidaTM on Liver Fat Content, Body Fat Distribution and Insulin Sensitivity

NCT01635114 is registered in ClinicalTrials.gov with University Hospital Tuebingen as lead sponsor.

NCT NCT01635114
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01635114 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluate the Effects of resVidaTM on Liver Fat Content, Body Fat Distribution and Insulin Sensitivity
Lead sponsor
University Hospital Tuebingen
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2012
Completion date
September 30, 2015
Enrollment
112 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

elevated liver fat content and insulin resistance